Aussie Scientist's Final Farewell: Legacy in Cancer Research

Professor Richard Scolyer AO, a distinguished figure in cancer research, has authored a heartfelt farewell letter to the Australian public, to be published posthumously. He lived with glioblastoma for three years, openly documenting his experience to provide transparency and inspiration for cancer patients and their families.

With a 35-year career dedicated to patient care and research, Professor Scolyer made significant strides in melanoma diagnosis and treatment, including immunotherapy. He established the world's largest melanoma biobank and authored over 1,000 research publications, becoming a leading authority in his field.

He was the first patient to receive experimental brain cancer treatment derived from his own melanoma research. Professor Scolyer also participated in a brain cancer clinical trial, advocating for increased investment in this area.

His letter emphasizes that while cancer presents immense challenges, it does not define a person. He highlighted the importance of family, relationships, and compassion, urging continued support for scientific and medical research.

Professor Scolyer expressed gratitude for the love and support received from his family, friends, and the wider Australian community, including during his time as joint 2024 Australian of the Year. He hopes his legacy will inspire others to pursue their passions with humility and compassion.